Hans Lindgren

Long Term Results of a Randomised Trial of Stenting of the Superficial Femoral Artery for Intermittent Claudication.
Gunnarsson T, Bergman S, Pärsson H, Gottsäter A, Lindgren H. Eur J Vasc Endovasc Surg. 2023 Jan 12:S1078-5884(23)00006-0. doi: 10.1016/j.ejvs.2023.01.004. Online ahead of print.PMID: 36642399 

Eight-year outcome after invasive treatment of infrainguinal intermittent claudication: A population-based analysis from the Swedish vascular register (Swedvasc).
Gunnarsson T, Gottsäter A, Bergman S, Troëng T, Lindgren H.
SAGE Open Med. 2020 May 24;8:2050312120926782. doi: 10.1177/2050312120926782. eCollection 2020.PMID: 32547751 Free PMC article.

Primary Stenting of the Superficial Femoral Artery in Patients with Intermittent Claudication Has Durable Effects on Health-Related Quality of Life at 24 Months: Results of a Randomized Controlled Trial.

Lindgren HIV, Qvarfordt P, Bergman S, Gottsäter A; Swedish Endovascular Claudication Stenting Trialists.

Cardiovasc Intervent Radiol. 2018 Jun;41(6):872-881. doi: 10.1007/s00270-018-1925-0. Epub 2018 Mar 8.

PMID: 29520431

Primary Stenting of the Superficial Femoral Artery in Intermittent Claudication Improves Health Related Quality of Life, ABI and Walking Distance: 12 Month Results of a Controlled Randomised Multicentre Trial.

Lindgren H, Qvarfordt P, Åkesson M, Bergman S, Gottsäter A; Swedish Endovascular Claudication Stenting Trialists.

Eur J Vasc Endovasc Surg. 2017 May;53(5):686-694. doi: 10.1016/j.ejvs.2017.01.026. Epub 2017 Mar 31.

PMID: 28372983

Gender differences in outcome after stent treatment of lesions in the femoropopliteal segment.
Lindgren H, Gottsäter A, Hermansson K, Qvarfordt P, Bergman S.
Scand J Surg. 2012;101(3):177-83.

The use and diagnostic yield of radiology in subjects with longstanding musculoskeletal pain–an eight year follow up.
Lindgren H, Bergman S.
BMC Musculoskelet Disord. 2005 Nov 3;6:53.